Follow
Xavier Calvo
Xavier Calvo
Hematologist, Hospital del Mar, Barcelona
Verified email at psmar.cat - Homepage
Title
Cited by
Cited by
Year
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive …
E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ...
Haematologica 95 (9), 1526, 2010
2132010
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients
A Martínez-Trillos, A Gaya, M Maffioli, E Arellano-Rodrigo, X Calvo, ...
Annals of hematology 89, 1233-1237, 2010
2082010
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
M Granell, X Calvo, A Garcia-Guiñón, L Escoda, E Abella, CM Martínez, ...
Haematologica 102 (6), 1099, 2017
1072017
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
P Abrisqueta, N Villamor, MJ Terol, E González-Barca, M González, ...
Blood, The Journal of the American Society of Hematology 122 (24), 3951-3959, 2013
812013
Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale
S Bonanad, J De la Rubia, M Gironella, EP Persona, B González, ...
Journal of geriatric oncology 6 (5), 353-361, 2015
702015
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
A Kündgen, M Nomdedeu, H Tuechler, G Garcia-Manero, RS Komrokji, ...
Leukemia 35 (3), 835-849, 2021
662021
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ...
Leukemia 32 (6), 1427-1434, 2018
632018
Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
X Calvo, N Garcia-Gisbert, I Parraga, J Gibert, L Florensa, ...
Blood Advances 4 (20), 5285-5296, 2020
332020
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome
X Calvo, M Nomdedeu, A Navarro, R Tejero, D Costa, C Muñoz, A Pereira, ...
Leukemia research 38 (8), 874-881, 2014
292014
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
G Blanco, A Vardi, A Puiggros, A Gómez-Llonín, M Muro, ...
Oncoimmunology 7 (6), e1432328, 2018
272018
Optical Genome Mapping: A promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL)
A Puiggros, S Ramos-Campoy, J Kamaso, M de la Rosa, M Salido, ...
Cancers 14 (14), 3376, 2022
262022
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma
C Recasens-Zorzo, T Cardesa-Salzmann, P Petazzi, L Ros-Blanco, ...
haematologica 104 (4), 778, 2019
232019
Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes
L Arenillas, X Calvo, E Luño, L Senent, E Alonso, F Ramos, MT Ardanaz, ...
J Clin Oncol 34 (27), 3284-3292, 2016
232016
Loss of the immune checkpoint CD85j/LILRB1 on malignant plasma cells contributes to immune escape in multiple myeloma
E Lozano, T Díaz, MP Mena, G Suñe, X Calvo, M Calderón, L Pérez-Amill, ...
The Journal of Immunology 200 (8), 2581-2591, 2018
222018
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients
S Ramos-Campoy, A Puiggros, S Beà, S Bougeon, MJ Larráyoz, D Costa, ...
Haematologica 107 (3), 593, 2022
212022
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
M Nomdedeu, A Pereira, X Calvo, J Colomer, F Sole, A Arias, C Gomez, ...
Leukemia research 63, 85-89, 2017
192017
LMO2-negative expression predicts the presence of MYC translocations in aggressive B-cell lymphomas
L Colomo, I Vazquez, N Papaleo, B Espinet, A Ferrer, C Franco, ...
The American Journal of Surgical Pathology 41 (7), 877-886, 2017
192017
Excess mortality in the myelodysplastic syndromes
M Nomdedeu, A Pereira, F Ramos, D Valcárcel, D Costa, M Arnan, ...
American Journal of Hematology 92 (2), 149-154, 2017
192017
Serial intestinal endoscopic examinations of patients with persistent diarrhea after allo-SCT
C Martínez, M Rosales, X Calvo, M Cuatrecasas, L Rodriguez-Carunchio, ...
Bone marrow transplantation 47 (5), 694-699, 2012
182012
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of …
X Calvo, L Arenillas, E Luño, L Senent, M Arnan, F Ramos, MT Ardanaz, ...
Modern Pathology 29 (12), 1541-1551, 2016
172016
The system can't perform the operation now. Try again later.
Articles 1–20